secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neurogene Inc. (NGNE)
CIK:        0001404644
Form:       8-K
Filed at:   2023-12-04T23:59:59+00:00
Accession:  0001193125-23-288502
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neoleukin revises CVR agreement with $500K de minimis threshold and unused lease holdback inclusion
--------------------------------------------------------------------------------

- Revised CVR Agreement adds a $500,000 de minimis threshold for CVR payments; unpaid amounts distributed by June 30, 2029.
- 100% of unused Lease Negotiation Holdback balance included in Gross Proceeds for CVR payments.
- Amendment relates to the pending merger with Neurogene; closing expected under prior merger agreement.
- CVR term ends June 30, 2029; payments made in cash or stock at company's discretion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404644/000119312523288502/0001193125-23-288502-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404644/000119312523288502/d595715d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-288502

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer